Get the latest on new medications approved and marketed in 2020—including their indications for use, routes of administration, and associated precautions. This can’t-miss session will review a selection of new therapeutic agents and their role in therapy. Where applicable, presenters will compare new therapies with existing agents and help you determine whether newer is better. Patient education tips and practical monitoring considerations round out this valuable update.
At the completion of this knowledge-based activity, participants will be able to:
- List new therapeutic agents that were approved by the U.S. Food and Drug Administration and first marketed in 2020.
- Describe the mechanisms of action and indications for new therapeutic agents first marketed in 2020.
- Summarize adverse effects and patient safety considerations for new therapeutic agents first marketed in 2020.
- Compare new therapeutic agents first marketed in 2020 with other available therapeutic options.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-025-H01-P
To obtain credit for Your Annual New Drugs Update, participants will need to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.Initial release date: March 15, 2021
Expiration date: March 15, 2024 - No credit granted after this date
Your Annual New Drugs Update is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2021 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-025-H01-P||0.15 CEUs||March 15, 2021 - March 15, 2024|